Hansa Biopharma AB (publ) (LON:0RC7)
22.72
-0.92 (-3.89%)
At close: Feb 21, 2025
Hansa Biopharma AB Revenue
In the year 2024, Hansa Biopharma AB had annual revenue of 171.32M SEK with 27.76% growth. Hansa Biopharma AB had revenue of 32.34M in the quarter ending December 31, 2024, a decrease of -35.85%.
Revenue
171.32M SEK
Revenue Growth
+27.76%
P/S Ratio
n/a
Revenue / Employee
1.27M SEK
Employees
135
Market Cap
113.91M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 171.32M | 37.22M | 27.76% |
Dec 31, 2023 | 134.09M | -20.43M | -13.22% |
Dec 31, 2022 | 154.53M | 120.65M | 356.12% |
Dec 31, 2021 | 33.88M | 27.78M | 455.56% |
Dec 31, 2020 | 6.10M | 2.73M | 81.27% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Genus | 668.80M |